SEC Form 4 · accession 0000357097-15-000058
Fibrocell Science, Inc. · FCSC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc Mazur
Director
Period of report
Jun 24, 2015
Accepted (ET)
Jun 25, 2015 · 12:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000357097
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF2,F1 | $5.44 | Jun 24, 2015 | A | 36,000 | A | — | Jun 24, 2025 | Common Stock | 36,000 | 36,000 | D |
Explanation of responses
- F1These options are exercisable with respect to 18,000 options immediately upon the date of grant and exercisable with respect to the remaining 18,000 options on the one year anniversary of the date of grant.
- F2The options were issued in connection with the reporting person's service to the Company as a member of its Board of Directors.